Companies spend billions on programs that don’t pay off. Here’s how to fix that. by Michael Beer, Magnus Finnström and Derek Schrader Corporations are victims of the great training robbery. American ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.
Abstract: Intelligent reflecting surface (IRS) is an enabling technology to engineer the radio signal propagation in wireless networks. By smartly tuning the signal reflection via a large number of ...
Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...
Training for School Personnel is designed for people who work with children and youth in school settings. This program provides an overview of seizures and epilepsy, seizure first aid, seizure action ...
The global CGM market is projected to reach a valuation of $15.69bn in 2035, as per GlobalData analysis. Credit: Around the World Photos / Shutterstock.com The US Food and Drug Administration (FDA) ...
The 15-day G7 CGM in use. [Image courtesy of Dexcom] Nearly halfway through 2026, the milestones are already stacking up for continuous glucose monitor (CGM) maker Dexcom (Nadsaq:DXCM). Finally, last ...
The CONNECT trial, presented at the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, found that 82% of adults with type 2 diabetes who used a Dexcom G7 improved their blood ...
Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...
Abstract: While celebrating the 21st year since the very first IEEE 802.11 “legacy” 2 Mbit/s wireless local area network standard, the latest Wi-Fi newborn is today reaching the finish line, topping ...
A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced findings from a study demonstrating the benefits of its G7 CGM in type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results